| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/24/2008 | CA2666406A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/24/2008 | CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | CA2664849A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/23/2008 | EP1914236A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1912979A2 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 04/23/2008 | EP1912973A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
| 04/23/2008 | EP1912971A2 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912969A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 04/23/2008 | EP1912968A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| 04/23/2008 | EP1912967A1 Quinoline derivatives as neurokinin receptor antagonists |
| 04/23/2008 | EP1912966A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 04/23/2008 | EP1912953A1 Process for the synthesis of rosuvastatin calcium |
| 04/23/2008 | EP1912948A1 Antibacterial quinoline derivatives |
| 04/23/2008 | EP1912947A1 Isotopically substituted pantoprazole |
| 04/23/2008 | EP1912940A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 04/23/2008 | EP1912939A1 Metabotropic glutamate-receptor-potentiating isoindolones |
| 04/23/2008 | EP1912706A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1802578B1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/23/2008 | EP1689493A4 Calcitonin gene related peptide receptor antagonists |
| 04/23/2008 | EP1615896B1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/23/2008 | EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | EP0974587B1 1-substituted 4-carbamoyl-1,2,4-triazol-5-one derivatives and herbicide |
| 04/23/2008 | CN101166794A Cationic compound, dye compound, method for using the same and optical information recording medium |
| 04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166732A Cyanopyridine derivative and use thereof as medicine |
| 04/23/2008 | CN101166731A Herbicidally active phenylsulphonyl-urea |
| 04/23/2008 | CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 04/23/2008 | CN101166725A Pyridylacetic acid compound |
| 04/23/2008 | CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators |
| 04/23/2008 | CN101165061A Hetero triazine compounds |
| 04/23/2008 | CN101165054A Method for synthesizing 1-hydroxy-1,2,4,5-tetrapyridylcyclohexane |
| 04/23/2008 | CN101165053A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165052A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165050A Benzoisoindole derivative, pigment composition comprising the same and colored composition |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100383118C 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/22/2008 | US7361768 Reacting nicotine with trimethylsilylchloride and lithium in polar aprotic solvent to form 3-(1-methylpyrrolidin-2-yl)-1,4-bis-trimethylsilanyl-1,4-dihydropyridine; chemical intermediates such as to nicotinic acetylcholine receptor modulators |
| 04/22/2008 | US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine |
| 04/22/2008 | US7361682 Indole derivatives as H3 inverse agonists |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361672 Pyrazoles, triazoles, or tetrazoles substituted with an aryl- or heteroarylcarbonylamino group and an aminocarbonylmethyl group: 5-chloro-thiophene-2-carboxylic acid (1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-1H-[1,2,4]triazol-3-yl)-amide; improved selectivity towards thrombin |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361669 particularly useful for treating cardiovascular disease |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361658 2-acylaminothiazole derivative or salt thereof |
| 04/22/2008 | US7361657 Drugs for treatment of respiratory syncytial virus and salt formation |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/22/2008 | CA2261628C Process for preparing 3-pyrroline-2-carboxylic acid derivatives |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008046085A2 Quinoline derivatives for modulating dna methylation |
| 04/17/2008 | WO2008045978A1 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 04/17/2008 | WO2008045668A1 Heterocyclic derived metalloprotease inhibitors |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044337A1 γ-GLOBIN INDUCER |
| 04/17/2008 | WO2008044217A2 2-aminocarbonyl-pyridine derivatives |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043775A1 Substituted pyrazinone derivatives for use as a medicine |
| 04/17/2008 | WO2008043759A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008043183A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/17/2008 | WO2008027542A3 5-substituted isoindoline compounds |
| 04/17/2008 | WO2008022164A3 Pyrazine compounds, their use and methods of preparation |
| 04/17/2008 | WO2008022046A3 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 04/17/2008 | WO2008021491A3 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones |
| 04/17/2008 | WO2008020302A3 Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
| 04/17/2008 | WO2008013660A3 Inhibitors of advanced glycation end products |
| 04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
| 04/17/2008 | WO2008010061A3 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 04/17/2008 | WO2008008887A3 Gpr119 agonists for treating metabolic disorders |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080091034 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |